EUROCINE VACCINES NAM.
Nidhogg Resources Holding AB (publ) engages in the mining business in Sweden. The company explores for iron, manganese, REE metals, copper, molybdenum, oil and gas, and non-carbon hydrogen. Nidhogg Resources Holding AB (publ) is based in Jönköping, Sweden.
EUROCINE VACCINES NAM. (8X4) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, EUROCINE VACCINES NAM. (8X4) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
EUROCINE VACCINES NAM. - Net Assets Trend (None–None)
This chart illustrates how EUROCINE VACCINES NAM.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EUROCINE VACCINES NAM. (None–None)
The table below shows the annual net assets of EUROCINE VACCINES NAM. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to EUROCINE VACCINES NAM.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
EUROCINE VACCINES NAM. Competitors by Market Cap
The table below lists competitors of EUROCINE VACCINES NAM. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GI Group Poland S.A.
WAR:GIG
|
$3.95 Million |
|
Arihant Foundations & Housing Limited
NSE:ARIHANT
|
$3.95 Million |
|
Goldstone Technologies Limited
NSE:GOLDTECH
|
$3.95 Million |
|
Mighty Kingdom Ltd
AU:MKL
|
$3.95 Million |
|
Maral Overseas Limited
NSE:MARALOVER
|
$3.95 Million |
|
Lysaght Galvanized Steel Bhd
KLSE:9199
|
$3.95 Million |
|
Banco Actinver S.A. Institución de Banca Múltiple Grupo Financiero Actinver
MX:FNOVA17
|
$3.95 Million |
|
Kioson Komersial Indonesia Tbk PT
JK:KIOS
|
$3.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EUROCINE VACCINES NAM.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares EUROCINE VACCINES NAM.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently EUROCINE VACCINES NAM. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares EUROCINE VACCINES NAM.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EUROCINE VACCINES NAM. (8X4) | €- | N/A | N/A | $3.95 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |